Pancreatic Cancer Clinical Trials in Shanghai, Shanghai Municipality
48 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 48 trials
Recruiting
Phase 3
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
Pancreatic Cancer
Akeso999 enrolled3 locationsNCT06953999
Recruiting
Phase 2
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
Pancreatic Cancer
Akeso160 enrolled2 locationsNCT07114315
Recruiting
Phase 3
Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Pancreatic Cancer Metastatic
Shanghai Yizhong Pharmaceutical Co., Ltd.416 enrolled2 locationsNCT06752811
Recruiting
Not Applicable
Target-specific immunoPET Imaging of Digestive System Carcinoma
MalignancyLiver CancerPancreatic Cancer+12 more
RenJi Hospital400 enrolled1 locationNCT06715839
Recruiting
Early Phase 1
A Study of GC203 TIL in PDCA (RJ)
Pancreatic CancerTreatment Side EffectsTumor Infiltrating Lymphocytes+1 more
Shanghai Juncell Therapeutics10 enrolled1 locationNCT06828328
Recruiting
Early Phase 1
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
Pancreatic Cancer ResectableChemotherapy-intolerant
Ruijin Hospital20 enrolled1 locationNCT06496373
Recruiting
Not Applicable
PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.
Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine200 enrolled1 locationNCT07167264
Recruiting
Phase 3
A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)
Pancreatic Cancer
Innovent Biologics (Suzhou) Co. Ltd.201 enrolled1 locationNCT07066098
Recruiting
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
Gastric CancersEsophageal CancerCancer Screening+14 more
Second Affiliated Hospital, School of Medicine, Zhejiang University600 enrolled4 locationsNCT06822413
Recruiting
Phase 1
Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC)
Unresectable Pancreatic Cancer
Chengdu New Radiomedicine Technology Co. LTD.58 enrolled6 locationsNCT06278454
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
Pancreatic Cancer
Ruijin Hospital30 enrolled1 locationNCT06601010
Recruiting
Not Applicable
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
Breast CancerLung CancersLiver Cancer+4 more
Guo ShiWei1,000,000 enrolled1 locationNCT06632886
Recruiting
Phase 1
IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations
Pancreatic Cancer
Shanghai Pudong Hospital12 enrolled1 locationNCT06487377
Recruiting
Phase 2
Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
Metastatic Pancreatic CancerTerminal Cancer
Fudan University20 enrolled1 locationNCT06018896
Recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
Pancreatic Cancer
CARsgen Therapeutics Co., Ltd.20 enrolled8 locationsNCT05911217
Recruiting
Phase 2
Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)
Pancreatic Cancer
Changhai Hospital67 enrolled1 locationNCT06427460
Recruiting
Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
Pancreatic CancerChronic Pancreatitis
Changhai Hospital600 enrolled1 locationNCT06411470
Recruiting
Phase 2
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Abbisko Therapeutics Co, Ltd82 enrolled5 locationsNCT06111274
Recruiting
Phase 2Phase 3
A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
Metastatic Pancreatic Cancer
1Globe Health Institute LLC336 enrolled38 locationsNCT03721744
Recruiting
Phase 3
A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer
Pancreatic Cancer Stage IVPancreatic Cancer Metastatic
RenJi Hospital401 enrolled6 locationsNCT04674956